Baseline visit and patient follow-up
| Time-points | |||
|---|---|---|---|
| Measure | Baseline | Every 2 years | Every 5 years |
| Consent form | ● | ● | ● |
| Baseline questionnaire (age, gender, smoking history, family history, medication history, symptoms and signs of HF) | ● | ● | |
| Follow-up questionnaire (including newly diagnosed cardiovascular or cerebrovascular events, kidney disease and DM) | ● | ● | |
| Body height, body weight, body mass index (BMI) and waist circumference and hip circumference | ● | ● | |
| Four-limb blood pressure measurement | ● | ● | |
| Office blood pressure measurement (3 times in a row) | ● | ● | ● |
| Venous blood biochemical parameters (blood glucose, blood lipid profile, serum creatinine and uric acid, pro-BNP, homocysteine) | ● | ● | ● |
| Urinalysis (urine microalbumin and urine creatinine) | ● | ● | |
| Blood and/or urine sample collection | ● | ● | ● |
| Electrocardiogram (rhythm, SV1+RV5) | ● | ● | |
| Vascular ultrasonography (bilateral carotid IMT) | ● | ● | |
| Echocardiography (LVM, LAV, LVEF, E/Ea, E/A) | ● | ● | |
| Determination of arterial elasticity (PWA, PWV) | ● | ● | |
| Evaluation of peripheral artery involvement | ● | ● | ● |
| Major adverse cardiovascular events | ● | ● | |
| Cardiovascular deaths | ● | ● | |
| All-cause deaths | ● | ● | |